-
1
-
-
0015522051
-
A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization
-
1:CAS:528:DyaE38XltFWrsLY%3D 5079944
-
Holwerda DA. A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization. Eur J Biochem. 1972;28:334-9.
-
(1972)
Eur J Biochem
, vol.28
, pp. 334-339
-
-
Holwerda, D.A.1
-
2
-
-
29744438811
-
Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin
-
1:CAS:528:DC%2BD28Xitlyguw%3D%3D 16269513
-
Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem. 2006;52:112-9.
-
(2006)
Clin Chem
, vol.52
, pp. 112-119
-
-
Morgenthaler, N.G.1
Struck, J.2
Alonso, C.3
Bergmann, A.4
-
3
-
-
84976585191
-
Increased Levels of Copeptin, a Surrogate Marker of Arginine Vasopressin, Are Associated with an Increased Risk of Chronic Kidney Disease in a General Population
-
1:CAS:528:DC%2BC28Xht1Gitb7K 27347674
-
Tasevska I, Enhörning S, Christensson A, Persson M, Nilsson PM, Melander O. Increased Levels of Copeptin, a Surrogate Marker of Arginine Vasopressin, Are Associated with an Increased Risk of Chronic Kidney Disease in a General Population. Am J Nephrol. 2016;44:22-8.
-
(2016)
Am J Nephrol
, vol.44
, pp. 22-28
-
-
Tasevska, I.1
Enhörning, S.2
Christensson, A.3
Persson, M.4
Nilsson, P.M.5
Melander, O.6
-
4
-
-
84958117112
-
Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis
-
1:CAS:528:DC%2BC28XhsVKisrY%3D 26794439
-
Christ-Crain M, Fenske W. Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis. Nat Rev Endocrinol. 2016;12:168-76.
-
(2016)
Nat Rev Endocrinol
, vol.12
, pp. 168-176
-
-
Christ-Crain, M.1
Fenske, W.2
-
5
-
-
84977654423
-
Elevated copeptin is a prognostic factor for mortality even in patients with renal dysfunction
-
Engelbertz C, Brand E, Fobker M, Fischer D, Pavenstädt H. Reinecke H Elevated copeptin is a prognostic factor for mortality even in patients with renal dysfunction. Int J Cardiol. 2016;221:327-32.
-
(2016)
Int J Cardiol
, vol.221
, pp. 327-332
-
-
Engelbertz, C.1
Brand, E.2
Fobker, M.3
Fischer, D.4
Pavenstädt, H.5
Reinecke, H.6
-
6
-
-
84876184092
-
Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: The prospective Malmö Diet and Cancer Study cardiovascular cohort
-
Enhörning S, Bankir L, Bouby N, Struck J, Hedblad B, Persson M, Morgenthaler NG, Nilsson PM, Melander O. Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort. Int J Obes (Lond). 2013;37:598-603.
-
(2013)
Int J Obes (Lond)
, vol.37
, pp. 598-603
-
-
Enhörning, S.1
Bankir, L.2
Bouby, N.3
Struck, J.4
Hedblad, B.5
Persson, M.6
Morgenthaler, N.G.7
Nilsson, P.M.8
Melander, O.9
-
7
-
-
84941712330
-
Copeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men
-
1:CAS:528:DC%2BC28XotlCrtA%3D%3D 26158609 4570154
-
Wannamethee SG, Welsh P, Papacosta O, Lennon L, Whincup PH, Sattar N. Copeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men. J Clin Endocrinol Metab. 2015;100:3332-9.
-
(2015)
J Clin Endocrinol Metab
, vol.100
, pp. 3332-3339
-
-
Wannamethee, S.G.1
Welsh, P.2
Papacosta, O.3
Lennon, L.4
Whincup, P.H.5
Sattar, N.6
-
8
-
-
60549098799
-
Gender and renalfunction influence plasma levels of copeptin in healthy individuals
-
1:CAS:528:DC%2BD1MXis1Oisw%3D%3D
-
Bhandari SS, Loke I, Davies JE, Squire IB, Struck J, Ng LL. Gender and renalfunction influence plasma levels of copeptin in healthy individuals. Clin Sci(Lond). 2009;116:257-63.
-
(2009)
Clin Sci(Lond)
, vol.116
, pp. 257-263
-
-
Bhandari, S.S.1
Loke, I.2
Davies, J.E.3
Squire, I.B.4
Struck, J.5
Ng, L.L.6
-
9
-
-
84862194446
-
Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment
-
1:CAS:528:DC%2BC38XhtVOmsbbL 22516290
-
Zittema D, Boertien WE, van Beek AP, Dullaart RP, Franssen CF, de Jong PE, Meijer E, Gansevoort RT. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment. Clin J Am Soc Nephrol. 2012;7:906-13.
-
(2012)
Clin J Am Soc Nephrol
, vol.7
, pp. 906-913
-
-
Zittema, D.1
Boertien, W.E.2
Van Beek, A.P.3
Dullaart, R.P.4
Franssen, C.F.5
De Jong, P.E.6
Meijer, E.7
Gansevoort, R.T.8
-
10
-
-
84923800132
-
Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients
-
1:CAS:528:DC%2BC2cXhsl2mt77N 24993447 4152815
-
Zittema D, van den Berg E, Meijer E, Boertien WE, Muller Kobold AC, Franssen CF, de Jong PE, Bakker SJ, Navis G, Gansevoort RT. Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol. 2014;9:1553-62.
-
(2014)
Clin J Am Soc Nephrol
, vol.9
, pp. 1553-1562
-
-
Zittema, D.1
Van Den Berg, E.2
Meijer, E.3
Boertien, W.E.4
Muller Kobold, A.C.5
Franssen, C.F.6
De Jong, P.E.7
Bakker, S.J.8
Navis, G.9
Gansevoort, R.T.10
-
11
-
-
84930442582
-
Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study
-
1:CAS:528:DC%2BC2MXht1egs73O 25270071
-
Ponte B, Pruijm M, Ackermann D, Vuistiner P, Guessous I, Ehret G, Alwan H, Youhanna S, Paccaud F, Mohaupt M, Péchère-Bertschi A, Vogt B, Burnier M, Martin PY, Devuyst O, Bochud M. Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study. J Am Soc Nephrol. 2015;26:1415-25.
-
(2015)
J Am Soc Nephrol
, vol.26
, pp. 1415-1425
-
-
Ponte, B.1
Pruijm, M.2
Ackermann, D.3
Vuistiner, P.4
Guessous, I.5
Ehret, G.6
Alwan, H.7
Youhanna, S.8
Paccaud, F.9
Mohaupt, M.10
Péchère-Bertschi, A.11
Vogt, B.12
Burnier, M.13
Martin, P.Y.14
Devuyst, O.15
Bochud, M.16
-
12
-
-
72949095441
-
Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort
-
1:CAS:528:DC%2BD1MXhsFGms7rP 19847155
-
Meijer E, Bakker SJ, Halbesma N, de Jong PE, Struck J, Gansevoort RT. Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort. Kidney Int. 2010;77:29-36.
-
(2010)
Kidney Int
, vol.77
, pp. 29-36
-
-
Meijer, E.1
Bakker, S.J.2
Halbesma, N.3
De Jong, P.E.4
Struck, J.5
Gansevoort, R.T.6
-
13
-
-
84875758393
-
Vasopressin: A novel target for the prevention and retardation of kidney disease?
-
1:CAS:528:DC%2BC3sXltVWrurc%3D 23438973
-
Bankir L, Bouby N, Ritz E. Vasopressin: a novel target for the prevention and retardation of kidney disease? Nat Rev Nephrol. 2013;9:223-39.
-
(2013)
Nat Rev Nephrol
, vol.9
, pp. 223-239
-
-
Bankir, L.1
Bouby, N.2
Ritz, E.3
-
14
-
-
0041883699
-
Diabetes-induced albuminuria: Role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats
-
1:CAS:528:DC%2BD3sXnvF2lu74%3D 12937221
-
Bardoux P, Bruneval P, Heudes D, Bouby N, Bankir L. Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats. Nephrol Dial Transplant. 2003;18:1755-63.
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 1755-1763
-
-
Bardoux, P.1
Bruneval, P.2
Heudes, D.3
Bouby, N.4
Bankir, L.5
-
15
-
-
0030369740
-
Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action
-
1:CAS:528:DyaK28XkslWrtLw%3D 8793792
-
Bouby N, Ahloulay M, Nsegbe E, Déchaux M, Schmitt F, Bankir L. Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action. J Am Soc Nephrol. 1996;7:842-51.
-
(1996)
J Am Soc Nephrol
, vol.7
, pp. 842-851
-
-
Bouby, N.1
Ahloulay, M.2
Nsegbe, E.3
Déchaux, M.4
Schmitt, F.5
Bankir, L.6
-
16
-
-
84883303780
-
Copeptin and cardiovascular disease: A review of a novel neurohormone
-
23298558
-
Yalta K, Yalta T, Sivri N, Yetkin E. Copeptin and cardiovascular disease: a review of a novel neurohormone. Int J Cardiol. 2013;167:1750-9.
-
(2013)
Int J Cardiol
, vol.167
, pp. 1750-1759
-
-
Yalta, K.1
Yalta, T.2
Sivri, N.3
Yetkin, E.4
-
17
-
-
77955168878
-
Copeptin: A biomarker of cardiovascular and renal function
-
1:CAS:528:DC%2BC3cXhtFGnurzM 20653710
-
Morgenthaler NG. Copeptin: a biomarker of cardiovascular and renal function. Congest Heart Fail. 2010;16:S37-44.
-
(2010)
Congest Heart Fail
, vol.16
, pp. S37-44
-
-
Morgenthaler, N.G.1
-
18
-
-
79953300299
-
Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus
-
German Diabetes, Dialysis Study Investigators 1:CAS:528:DC%2BC3MXlslOjs7c%3D 21415158 3065233
-
Fenske W, Wanner C, Allolio B, Drechsler C, Blouin K, Lilienthal J, Krane V, German Diabetes, Dialysis Study Investigators. Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus. J Am Soc Nephrol. 2011;22:782-90.
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 782-790
-
-
Fenske, W.1
Wanner, C.2
Allolio, B.3
Drechsler, C.4
Blouin, K.5
Lilienthal, J.6
Krane, V.7
-
19
-
-
80655131138
-
Urine volume and change in estimated GFR in a community-based cohort study
-
1:CAS:528:DC%2BC3MXhs1KjtrnK 21885793 3359569
-
Clark WF, Sontrop JM, Macnab JJ, Suri RS, Moist L, Salvadori M, Garg AX. Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol. 2011;6:2634-41.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 2634-2641
-
-
Clark, W.F.1
Sontrop, J.M.2
Macnab, J.J.3
Suri, R.S.4
Moist, L.5
Salvadori, M.6
Garg, A.X.7
-
20
-
-
0025209989
-
Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat
-
1:CAS:528:DyaK3cXitlentL4%3D 2184677
-
Bouby N, Bachmann S, Bichet D, Bankir L. Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat. Am J Physiol. 1990;258:F973-9.
-
(1990)
Am J Physiol
, vol.258
, pp. F973-F979
-
-
Bouby, N.1
Bachmann, S.2
Bichet, D.3
Bankir, L.4
-
21
-
-
0033618611
-
Contribution of vasopressin to progression of chronic renal failure: Study in Brattleboro rats
-
1:CAS:528:DyaK1MXlt1CksLo%3D 10499867
-
Bouby N, Hassler C, Bankir L. Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats. Life Sci. 1999;65:991-1004.
-
(1999)
Life Sci
, vol.65
, pp. 991-1004
-
-
Bouby, N.1
Hassler, C.2
Bankir, L.3
-
22
-
-
0032894253
-
High water intake ameliorates tubulointerstitial injury in rats with subtotal nephrectomy: Possible role of TGF-beta
-
1:CAS:528:DyaK1MXjtVOgsL8%3D 10231442
-
Sugiura T, Yamauchi A, Kitamura H, Matsuoka Y, Horio M, Imai E, Hori M. High water intake ameliorates tubulointerstitial injury in rats with subtotal nephrectomy: possible role of TGF-beta. Kidney Int. 1999;55:1800-10.
-
(1999)
Kidney Int
, vol.55
, pp. 1800-1810
-
-
Sugiura, T.1
Yamauchi, A.2
Kitamura, H.3
Matsuoka, Y.4
Horio, M.5
Imai, E.6
Hori, M.7
-
23
-
-
0035101494
-
Vasopressin and diabetes mellitus
-
1:CAS:528:DC%2BD3MXht1agurs%3D 11174021
-
Bankir L, Bardoux P, Ahloulay M. Vasopressin and diabetes mellitus. Nephron. 2001;87:8-18.
-
(2001)
Nephron
, vol.87
, pp. 8-18
-
-
Bankir, L.1
Bardoux, P.2
Ahloulay, M.3
-
24
-
-
77955922264
-
Vasopressin beyond water: Implications for renal diseases
-
1:CAS:528:DC%2BC3cXpvFKnsbY%3D 20689424
-
Bolignano D, Zoccali C. Vasopressin beyond water: implications for renal diseases. Curr Opin Nephrol Hypertens. 2010;19:499-504.
-
(2010)
Curr Opin Nephrol Hypertens
, vol.19
, pp. 499-504
-
-
Bolignano, D.1
Zoccali, C.2
-
25
-
-
1342265782
-
Vasopressin stimulates insulin release from islet cells through V1b receptors: A combined pharmacological/knockout approach
-
1:CAS:528:DC%2BD2cXhs1KgtLs%3D 14978240
-
Oshikawa S, Tanoue A, Koshimizu TA, Kitagawa Y, Tsujimoto G. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach. Mol Pharmacol. 2004;65:623-9.
-
(2004)
Mol Pharmacol
, vol.65
, pp. 623-629
-
-
Oshikawa, S.1
Tanoue, A.2
Koshimizu, T.A.3
Kitagawa, Y.4
Tsujimoto, G.5
-
26
-
-
0021908941
-
The effect of vasopressin infusion on glucose metabolism in man
-
1:CAS:528:DyaL2MXktVSqsbg%3D
-
Spruce BA, McCulloch AJ, Burd J, Orskov H, Heaton A, Baylis PH, Alberti KG. The effect of vasopressin infusion on glucose metabolism in man. Clin Endocrinol (Oxf). 1985;22:463-8.
-
(1985)
Clin Endocrinol (Oxf)
, vol.22
, pp. 463-468
-
-
Spruce, B.A.1
McCulloch, A.J.2
Burd, J.3
Orskov, H.4
Heaton, A.5
Baylis, P.H.6
Alberti, K.G.7
-
27
-
-
58149239864
-
Altered lipid metabolism in vasopressin V1B receptor-deficient mice
-
1:CAS:528:DC%2BD1MXksVahsg%3D%3D 19068213
-
Hiroyama M, Fujiwara Y, Nakamura K, Aoyagi T, Mizutani R, Sanbe A, Tasaki R, Tanoue A. Altered lipid metabolism in vasopressin V1B receptor-deficient mice. Eur J Pharmacol. 2009;602:455-61.
-
(2009)
Eur J Pharmacol
, vol.602
, pp. 455-461
-
-
Hiroyama, M.1
Fujiwara, Y.2
Nakamura, K.3
Aoyagi, T.4
Mizutani, R.5
Sanbe, A.6
Tasaki, R.7
Tanoue, A.8
-
28
-
-
0023148935
-
Mechanism of vasopressin-induced platelet aggregation
-
1:CAS:528:DyaL2sXps1Gktw%3D%3D 3105115
-
Filep J, Rosenkranz B. Mechanism of vasopressin-induced platelet aggregation. Thromb Res. 1987;45:7-15.
-
(1987)
Thromb Res
, vol.45
, pp. 7-15
-
-
Filep, J.1
Rosenkranz, B.2
-
29
-
-
0033946470
-
Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP
-
1:CAS:528:DC%2BD3cXks1yrs7c%3D 10880054 314363
-
Kaufmann JE, Oksche A, Wollheim CB, Günther G, Rosenthal W, Vischer UM. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest. 2000;106:107-16.
-
(2000)
J Clin Invest
, vol.106
, pp. 107-116
-
-
Kaufmann, J.E.1
Oksche, A.2
Wollheim, C.B.3
Günther, G.4
Rosenthal, W.5
Vischer, U.M.6
-
30
-
-
0028045589
-
Vasoconstrictive peptides induce endothelin-1 and prostanoids in human cerebromicrovascular endothelium
-
1:CAS:528:DyaK2cXis1ahsLk%3D 8166228
-
Spatz M, Stanimirovic D, Bacic F, Uematsu S, McCarron RM. Vasoconstrictive peptides induce endothelin-1 and prostanoids in human cerebromicrovascular endothelium. Am J Physiol. 1994;266:C654-60.
-
(1994)
Am J Physiol
, vol.266
, pp. C654-C660
-
-
Spatz, M.1
Stanimirovic, D.2
Bacic, F.3
Uematsu, S.4
McCarron, R.M.5
-
31
-
-
0033665474
-
Perturbations of arginine vasopressin secretion during inflammatory stress. Pathophysiologic implications
-
1:CAS:528:DC%2BD3cXovFymtLc%3D 11268412
-
Chikanza IC, Petrou P, Chrousos G. Perturbations of arginine vasopressin secretion during inflammatory stress. Pathophysiologic implications. Ann N Y Acad Sci. 2000;917:825-34.
-
(2000)
Ann N y Acad Sci
, vol.917
, pp. 825-834
-
-
Chikanza, I.C.1
Petrou, P.2
Chrousos, G.3
-
32
-
-
84894227570
-
Serum copeptin levels in adolescents with primary hypertension
-
24375010
-
Tenderenda-Banasiuk E, Wasilewska A, Filonowicz R, Jakubowska U, Waszkiewicz-Stojda M. Serum copeptin levels in adolescents with primary hypertension. Pediatr Nephrol. 2014;29:423-9.
-
(2014)
Pediatr Nephrol
, vol.29
, pp. 423-429
-
-
Tenderenda-Banasiuk, E.1
Wasilewska, A.2
Filonowicz, R.3
Jakubowska, U.4
Waszkiewicz-Stojda, M.5
-
33
-
-
84937780338
-
Serum copeptin levels in predicting nondippers in newly diagnosed hypertension
-
25919790
-
Uzun F, Biyik I, Akturk IF, Yalcin AA, Erturk M, Oner E, Kalkan AK, Yalcin B, Atmaca H. Serum copeptin levels in predicting nondippers in newly diagnosed hypertension. Blood Press Monit. 2015;20:199-203.
-
(2015)
Blood Press Monit
, vol.20
, pp. 199-203
-
-
Uzun, F.1
Biyik, I.2
Akturk, I.F.3
Yalcin, A.A.4
Erturk, M.5
Oner, E.6
Kalkan, A.K.7
Yalcin, B.8
Atmaca, H.9
-
34
-
-
84941215479
-
Plasma copeptin levels and ambulatory blood pressure characteristics in healthy adults
-
1:CAS:528:DC%2BC2MXhtV2isrjO 26103126
-
Schoen T, Hohmann EM, Van Der Lely S, Aeschbacher S, Reusser A, Risch M, Risch L, Conen D. Plasma copeptin levels and ambulatory blood pressure characteristics in healthy adults. J Hypertens. 2015;33:1571-9.
-
(2015)
J Hypertens
, vol.33
, pp. 1571-1579
-
-
Schoen, T.1
Hohmann, E.M.2
Van Der Lely, S.3
Aeschbacher, S.4
Reusser, A.5
Risch, M.6
Risch, L.7
Conen, D.8
-
35
-
-
84991481643
-
Copeptin is increased in resistant hypertension
-
1:CAS:528:DC%2BC28XhslOhsrrE 27755389
-
Mendes M, Dubourg J, Blanchard A, Bergerot D, Courand PY, Forni V, Frank M, Bobrie G, Menard J, Azizi M. Copeptin is increased in resistant hypertension. J Hypertens. 2016;34:2458-64.
-
(2016)
J Hypertens
, vol.34
, pp. 2458-2464
-
-
Mendes, M.1
Dubourg, J.2
Blanchard, A.3
Bergerot, D.4
Courand, P.Y.5
Forni, V.6
Frank, M.7
Bobrie, G.8
Menard, J.9
Azizi, M.10
-
36
-
-
0021943360
-
The role of vasopressin in experimental and clinical hypertension
-
1:STN:280:DyaL2M7ps1WksQ%3D%3D 3887902
-
Krakoff LR, Elijovich F, Barry C. The role of vasopressin in experimental and clinical hypertension. Am J Kidney Dis. 1985;5:A40-7.
-
(1985)
Am J Kidney Dis
, vol.5
, pp. A40-A47
-
-
Krakoff, L.R.1
Elijovich, F.2
Barry, C.3
-
37
-
-
0031011283
-
Role of vasopressin in essential hypertension: Racial differences
-
1:STN:280:DyaK2szhtlKjtQ%3D%3D 9170008
-
Bakris G, Bursztyn M, Gavras I, Bresnahan M, Gavras H. Role of vasopressin in essential hypertension: racial differences. J Hypertens. 1997;15:545-50.
-
(1997)
J Hypertens
, vol.15
, pp. 545-550
-
-
Bakris, G.1
Bursztyn, M.2
Gavras, I.3
Bresnahan, M.4
Gavras, H.5
-
38
-
-
0031278640
-
The role of vasopressin in essential hypertension. Plasma levels and effects of the V1 receptor antagonist OPC-21268 during different dietary sodium intakes
-
1:CAS:528:DyaK2sXotVCktb8%3D 9397242
-
Kawano Y, Matsuoka H, Nishikimi T, Takishita S, Omae T. The role of vasopressin in essential hypertension. Plasma levels and effects of the V1 receptor antagonist OPC-21268 during different dietary sodium intakes. Am J Hypertens. 1997;10:1240-4.
-
(1997)
Am J Hypertens
, vol.10
, pp. 1240-1244
-
-
Kawano, Y.1
Matsuoka, H.2
Nishikimi, T.3
Takishita, S.4
Omae, T.5
-
39
-
-
0022447565
-
Centralrenin-angiotensin system and the pathogenesis of DOCA-salt hypertension in rats
-
1:CAS:528:DyaL28XltFejs78%3D 3526927
-
Itaya Y, Suzuki H, Matsukawa S, Kondo K, Saruta T. Centralrenin-angiotensin system and the pathogenesis of DOCA-salt hypertension in rats. Am J Physiol. 1986;251:H261-8.
-
(1986)
Am J Physiol
, vol.251
, pp. H261-H268
-
-
Itaya, Y.1
Suzuki, H.2
Matsukawa, S.3
Kondo, K.4
Saruta, T.5
-
40
-
-
68349133590
-
AngiotensinII type 2 receptors have a major somatodendritic distribution in vasopressin-containing neurons in the mouse hypothalamic paraventricular nucleus
-
1:CAS:528:DC%2BD1MXhtVSnu7rI 19539723 2740934
-
Coleman CG, Anrather J, Iadecola C, Pickel VM. AngiotensinII type 2 receptors have a major somatodendritic distribution in vasopressin-containing neurons in the mouse hypothalamic paraventricular nucleus. Neuroscience. 2009;163:129-42.
-
(2009)
Neuroscience
, vol.163
, pp. 129-142
-
-
Coleman, C.G.1
Anrather, J.2
Iadecola, C.3
Pickel, V.M.4
-
41
-
-
54749134723
-
Sodiumexcretion in response to vasopressin and selective vasopressin receptor antagonists
-
1:CAS:528:DC%2BD1cXhtFensrvE 18596120 2518442
-
Perucca J, Bichet DG, Bardoux P, Bouby N, Bankir L. Sodiumexcretion in response to vasopressin and selective vasopressin receptor antagonists. J Am Soc Nephrol. 2008;19:1721-31.
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 1721-1731
-
-
Perucca, J.1
Bichet, D.G.2
Bardoux, P.3
Bouby, N.4
Bankir, L.5
-
42
-
-
84994644840
-
Copeptin, resistant hypertension and renal sympathetic denervation
-
(epub ahead of print)
-
Schwerg M, Slagman A, Stangl K, Stangl V. Copeptin, resistant hypertension and renal sympathetic denervation. Biomarkers. 2016;8:1-4 (epub ahead of print).
-
(2016)
Biomarkers
, vol.8
, pp. 1-4
-
-
Schwerg, M.1
Slagman, A.2
Stangl, K.3
Stangl, V.4
-
43
-
-
70349093605
-
Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients
-
1:CAS:528:DC%2BD1MXhtVWrsL7N 19696640
-
Meijer E, Bakker SJ, de Jong PE, van der Heide JJ H, van Son WJ, Struck J, Lems SP, Gansevoort RT. Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients. Transplantation. 2009;88:561-7.
-
(2009)
Transplantation
, vol.88
, pp. 561-567
-
-
Meijer, E.1
Bakker, S.J.2
De Jong, P.E.3
Van Der Heide, J.J.H.4
Van Son, W.J.5
Struck, J.6
Lems, S.P.7
Gansevoort, R.T.8
-
44
-
-
79951914154
-
Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease
-
1:CAS:528:DC%2BC3MXjsFOgsL4%3D 20930090 3052227
-
Meijer E, Bakker SJ, van der Jagt EJ, Navis G, de Jong PE, Struck J, Gansevoort RT. Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2011;6:361-8.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 361-368
-
-
Meijer, E.1
Bakker, S.J.2
Van Der Jagt, E.J.3
Navis, G.4
De Jong, P.E.5
Struck, J.6
Gansevoort, R.T.7
-
45
-
-
84869428027
-
Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease
-
1:CAS:528:DC%2BC38Xhs1yns7zM 22523115
-
Boertien WE, Meijer E, Zittema D, van Dijk MA, Rabelink TJ, Breuning MH, Struck J, Bakker SJ, Peters DJ, de Jong PE, Gansevoort RT. Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2012;27:4131-7.
-
(2012)
Nephrol Dial Transplant
, vol.27
, pp. 4131-4137
-
-
Boertien, W.E.1
Meijer, E.2
Zittema, D.3
Van Dijk, M.A.4
Rabelink, T.J.5
Breuning, M.H.6
Struck, J.7
Bakker, S.J.8
Peters, D.J.9
De Jong, P.E.10
Gansevoort, R.T.11
-
46
-
-
84887622235
-
Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31)
-
1:CAS:528:DC%2BC3sXhs1ylt7fL 23757433 3781508
-
Riphagen IJ, Boertien WE, Alkhalaf A, Kleefstra N, Gansevoort RT, Groenier KH, van Hateren KJ, Struck J, Navis G, Bilo HJ, Bakker SJ. Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31). Diabetes Care. 2013;36:3201-7.
-
(2013)
Diabetes Care
, vol.36
, pp. 3201-3207
-
-
Riphagen, I.J.1
Boertien, W.E.2
Alkhalaf, A.3
Kleefstra, N.4
Gansevoort, R.T.5
Groenier, K.H.6
Van Hateren, K.J.7
Struck, J.8
Navis, G.9
Bilo, H.J.10
Bakker, S.J.11
-
47
-
-
84891854098
-
Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria
-
1:CAS:528:DC%2BC3sXhsl2ht7bE 23863910 3816878
-
Velho G, Bouby N, Hadjadj S, Matallah N, Mohammedi K, Fumeron F, Potier L, Bellili-Munoz N, Taveau C, Alhenc-Gelas F, Bankir L, Marre M, Roussel R. Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria. Diabetes Care. 2013;36:3639-45.
-
(2013)
Diabetes Care
, vol.36
, pp. 3639-3645
-
-
Velho, G.1
Bouby, N.2
Hadjadj, S.3
Matallah, N.4
Mohammedi, K.5
Fumeron, F.6
Potier, L.7
Bellili-Munoz, N.8
Taveau, C.9
Alhenc-Gelas, F.10
Bankir, L.11
Marre, M.12
Roussel, R.13
-
48
-
-
84879964727
-
Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33)
-
1:CAS:528:DC%2BC3sXhtVyrur%2FK 23624546
-
Boertien WE, Riphagen IJ, Drion I, Alkhalaf A, Bakker SJ, Groenier KH, Struck J, de Jong PE, Bilo HJ, Kleefstra N, Gansevoort RT. Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33). Diabetologia. 2013;56:1680-8.
-
(2013)
Diabetologia
, vol.56
, pp. 1680-1688
-
-
Boertien, W.E.1
Riphagen, I.J.2
Drion, I.3
Alkhalaf, A.4
Bakker, S.J.5
Groenier, K.H.6
Struck, J.7
De Jong, P.E.8
Bilo, H.J.9
Kleefstra, N.10
Gansevoort, R.T.11
-
49
-
-
84874117983
-
Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: Results from the CRISP cohort
-
Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease CRISP 1:CAS:528:DC%2BC38XhsFKns7vJ 23089511
-
Boertien WE, Meijer E, Li J, Bost JE, Struck J, Flessner MF, Gansevoort RT, Torres VE, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease CRISP. Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort. Am J Kidney Dis. 2013;61:420-9.
-
(2013)
Am J Kidney Dis
, vol.61
, pp. 420-429
-
-
Boertien, W.E.1
Meijer, E.2
Li, J.3
Bost, J.E.4
Struck, J.5
Flessner, M.F.6
Gansevoort, R.T.7
Torres, V.E.8
-
50
-
-
84875286370
-
Brain natriuretic peptide and copeptin levels are associated with cardiovascular disease in patients with chronic kidney disease
-
1:CAS:528:DC%2BC3sXpsVCmtbw%3D
-
Li X, Yang XC, Sun QM, Chen XD, Li YC. Brain natriuretic peptide and copeptin levels are associated with cardiovascular disease in patients with chronic kidney disease. Chin Med J (Engl). 2013;126:823-7.
-
(2013)
Chin Med J (Engl)
, vol.126
, pp. 823-827
-
-
Li, X.1
Yang, X.C.2
Sun, Q.M.3
Chen, X.D.4
Li, Y.C.5
-
51
-
-
85016754511
-
Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: Results from a pilot randomised controlled trial
-
House AA e008634 26603245 4663439
-
Sontrop JM, Huang SH, Garg AX, Moist L, House AA, Gallo K, Clark WF. Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial. BMJ Open. 2015;5, e008634.
-
(2015)
BMJ Open
, vol.5
-
-
Sontrop, J.M.1
Huang, S.H.2
Garg, A.X.3
Moist, L.4
Gallo, K.5
Clark, W.F.6
-
52
-
-
84941247629
-
Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D.E.S.I.R. Study
-
1:CAS:528:DC%2BC2MXhslCltbnE 26346607
-
Roussel R, Matallah N, Bouby N, El Boustany R, Potier L, Fumeron F, Mohammedi K, Balkau B, Marre M, Bankir L, Velho G. Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D.E.S.I.R. Study. Am J Nephrol. 2015;42:107-14.
-
(2015)
Am J Nephrol
, vol.42
, pp. 107-114
-
-
Roussel, R.1
Matallah, N.2
Bouby, N.3
El Boustany, R.4
Potier, L.5
Fumeron, F.6
Mohammedi, K.7
Balkau, B.8
Marre, M.9
Bankir, L.10
Velho, G.11
-
53
-
-
84938404709
-
Serum copeptin as a new biomarker in the early diagnosis of decline in renal function of type 2 diabetes mellitus patients
-
1:CAS:528:DC%2BC28XnsFeksbY%3D 26309649 4537970
-
Hu W, Ni YJ, Ma L, Hao HR, Chen L, Yu WN. Serum copeptin as a new biomarker in the early diagnosis of decline in renal function of type 2 diabetes mellitus patients. Int J Clin Exp Med. 2015;8:9730-6.
-
(2015)
Int J Clin Exp Med
, vol.8
, pp. 9730-9736
-
-
Hu, W.1
Ni, Y.J.2
Ma, L.3
Hao, H.R.4
Chen, L.5
Yu, W.N.6
-
54
-
-
84951908218
-
Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD)
-
1:CAS:528:DC%2BC2MXjsF2ntro%3D 25715868
-
Nakajima A, Lu Y, Kawano H, Horie S, Muto S. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD). Clin Exp Nephrol. 2015;19:1199-205.
-
(2015)
Clin Exp Nephrol
, vol.19
, pp. 1199-1205
-
-
Nakajima, A.1
Lu, Y.2
Kawano, H.3
Horie, S.4
Muto, S.5
-
55
-
-
84976526515
-
Plasma copeptin in children and adolescents with type 1 diabetes mellitus in comparison to healthy controls
-
1:CAS:528:DC%2BC28XhtVyiu7fF 27371782
-
Schiel R, Perenthaler TJ, Steveling A, Stein G. Plasma copeptin in children and adolescents with type 1 diabetes mellitus in comparison to healthy controls. Diabetes Res Clin Pract. 2016;118:156-61.
-
(2016)
Diabetes Res Clin Pract
, vol.118
, pp. 156-161
-
-
Schiel, R.1
Perenthaler, T.J.2
Steveling, A.3
Stein, G.4
|